Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

A novel therapeutic potential of cysteinyl leukotrienes and their receptors modulation in the neurological complications associated with Alzheimer's disease
Syed Obaidur Rahman, Rakesh Kumar Singh, Salman Hussain, et al.
European Journal of Pharmacology (2018) Vol. 842, pp. 208-220
Closed Access | Times Cited: 29

Showing 1-25 of 29 citing articles:

MSCs-Derived Exosomes Attenuate Acute Brain Injury and Inhibit Microglial Inflammation by Reversing CysLT2R-ERK1/2 Mediated Microglia M1 Polarization
Y Zhao, Yunxiao Gan, Gewei Xu, et al.
Neurochemical Research (2020) Vol. 45, Iss. 5, pp. 1180-1190
Closed Access | Times Cited: 85
Analysis of Neuropsychiatric Diagnoses After Montelukast Initiation
Tapio Paljärvi, Julian Forton, Sierra Luciano, et al.
JAMA Network Open (2022) Vol. 5, Iss. 5, pp. e2213643-e2213643
Open Access | Times Cited: 39
5-lipoxygenase pathway and its downstream cysteinyl leukotrienes as potential therapeutic targets for Alzheimer’s disease
Fang Chen, Arijit Ghosh, Jingran Lin, et al.
Brain Behavior and Immunity (2020) Vol. 88, pp. 844-855
Closed Access | Times Cited: 57
Drug Repositioning for Alzheimer’s Disease: Finding Hidden Clues in Old Drugs
Masafumi Ihara, Satoshi Saitô
Journal of Alzheimer s Disease (2020) Vol. 74, Iss. 4, pp. 1013-1028
Closed Access | Times Cited: 41
Inhibition of Rho Kinase by Fasudil Ameliorates Cognition Impairment in APP/PS1 Transgenic Mice via Modulation of Gut Microbiota and Metabolites
Yuqing Yan, Ye Gao, Qingli Fang, et al.
Frontiers in Aging Neuroscience (2021) Vol. 13
Open Access | Times Cited: 28
Transcriptome-based biomarker prediction for Parkinson’s disease using genome-scale metabolic modeling
Ecehan Abdi̇k, Tunahan Çakır
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 4
No association between proton pump inhibitor use and risk of dementia: Evidence from a meta‐analysis
Salman Hussain, Ambrish Singh, Saima Zameer, et al.
Journal of Gastroenterology and Hepatology (2019) Vol. 35, Iss. 1, pp. 19-28
Closed Access | Times Cited: 34
Potential Effects of Leukotriene Receptor Antagonist Montelukast in Treatment of Neuroinflammation in Parkinson’s Disease
Johan Wallin, Per Svenningsson
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 11, pp. 5606-5606
Open Access | Times Cited: 21
Neuromodulatory Effects of Leukotriene receptor antagonists: A comprehensive review
Radhika Sood, Shailendra Anoopkumar‐Dukie, Santosh Rudrawar, et al.
European Journal of Pharmacology (2024) Vol. 978, pp. 176755-176755
Open Access | Times Cited: 3
Leukotriene signaling in neurodegeneration: implications for treatment strategies
Veerta Sharma, Prateek Sharma, Thakur Gurjeet Singh
Inflammopharmacology (2024) Vol. 32, Iss. 6, pp. 3571-3584
Closed Access | Times Cited: 3
Montelukast Nanocrystals for Transdermal Delivery with Improved Chemical Stability
Sung Hyun Im, Hoe Taek Jung, Myoung Jin Ho, et al.
Pharmaceutics (2019) Vol. 12, Iss. 1, pp. 18-18
Open Access | Times Cited: 25
Recent Trends in the Management of Alzheimer’s Disease: Current Therapeutic Options and Drug Repurposing Approaches
Rakesh Kumar Singh
Current Neuropharmacology (2020) Vol. 18, Iss. 9, pp. 868-882
Open Access | Times Cited: 23
Alogliptin reversed hippocampal insulin resistance in an amyloid-beta fibrils induced animal model of Alzheimer's disease
Syed Obaidur Rahman, Madhu Kaundal, Mohd Salman, et al.
European Journal of Pharmacology (2020) Vol. 889, pp. 173522-173522
Closed Access | Times Cited: 22
CysLT2R Antagonist HAMI 3379 Ameliorates Post-Stroke Depression through NLRP3 Inflammasome/Pyroptosis Pathway in Gerbils
Li Zhou, Jiajia Zhang, Xue Han, et al.
Brain Sciences (2022) Vol. 12, Iss. 8, pp. 976-976
Open Access | Times Cited: 12
Montelukast: The New Therapeutic Option for the Treatment of Epilepsy
Bekalu Amare Tesfaye, Haftom Gebregergs Hailu, Kaleab Alemayehu Zewdie, et al.
Journal of Experimental Pharmacology (2021) Vol. Volume 13, pp. 23-31
Open Access | Times Cited: 14
Antagonism of cysteinyl leukotrienes and their receptors as a neuroinflammatory target in Alzheimer’s disease
Rakesh Kumar Singh
Neurological Sciences (2020) Vol. 41, Iss. 8, pp. 2081-2093
Closed Access | Times Cited: 13
Bioactive lipids and their metabolism: New therapeutic opportunities for Parkinson's disease
Wenjing Shen, Li Jiang, Jingyi Zhao, et al.
European Journal of Neuroscience (2021) Vol. 55, Iss. 3, pp. 846-872
Closed Access | Times Cited: 10
Quantitative Profiling of Oxylipins in Acute Experimental Intracerebral Hemorrhage
Junjie Yuan, Qiong Chen, Xiao‐Yi Xiong, et al.
Frontiers in Neuroscience (2020) Vol. 14
Open Access | Times Cited: 9
Anti-allergic, anti-asthmatic and anti-inflammatory effects of an oxazolidinone hydroxamic acid derivative (PH-251) – A novel dual inhibitor of 5-lipoxygenase and mast cell degranulation
Charles I. Ezeamuzie, Rao Ms, Ahmed Z. El‐Hashim, et al.
International Immunopharmacology (2022) Vol. 105, pp. 108558-108558
Open Access | Times Cited: 6
Fingerprint‐based computational models of 5‐lipo‐oxygenase activating protein inhibitors: Activity prediction and structure clustering
Guiping Tu, Zijian Qin, Donghui Huo, et al.
Chemical Biology & Drug Design (2020) Vol. 96, Iss. 3, pp. 931-947
Closed Access | Times Cited: 8
Anti-inflammatory constituents from the stems and leaves of Glycosmis ovoidea Pierre
Hongwei Chen, Jun Lin, Si-Si Zhu, et al.
Phytochemistry (2022) Vol. 203, pp. 113369-113369
Closed Access | Times Cited: 5
Montelukast microsuspension with hypromellose for improved stability and oral absorption
Ha Ryeong Lee, Hyun Jin Park, Jun Soo Park, et al.
International Journal of Biological Macromolecules (2021) Vol. 183, pp. 1732-1742
Closed Access | Times Cited: 7
Asthma aggravates alzheimer's disease by up-regulating NF- κB signaling pathway through LTD4
Xiaozhen Wang, Wenjing Gan, Meimei Kang, et al.
Brain Research (2023) Vol. 1825, pp. 148711-148711
Closed Access | Times Cited: 2
The Novel Potential Therapeutic Utility of Montelukast in Alleviating Autistic Behavior Induced by Early Postnatal Administration of Thimerosal in Mice
Lobna A. Abdelzaher, Ola A. Hussein, Israa El-Sayed Mohamed Ashry
Cellular and Molecular Neurobiology (2020) Vol. 41, Iss. 1, pp. 129-150
Closed Access | Times Cited: 4
Modifiable Innate Biology within the Gut–Brain Axis for Alzheimer’s Disease
Helena Marcos Pasero, Aurora García-Tejedor, Juan Antonio Giménez‐Bastida, et al.
Biomedicines (2022) Vol. 10, Iss. 9, pp. 2098-2098
Open Access | Times Cited: 2
Page 1 - Next Page

Scroll to top